Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pneumococcal vaccine
Biotech
GSK's new CEO looking for $2B-$4B deals 'hiding in plain sight'
Luke Miels had only been at the helm of GSK for 20 days when he signed off on his first multibillion-dollar buyout.
James Waldron
Feb 4, 2026 7:25am
GSK axes vaccine from $2.1B deal, switches to preclinical heir
Oct 30, 2024 7:06am
Vaxcyte surges on 'stunning' 31-valent PCV win against Pfizer
Sep 3, 2024 10:32am
Merck compares pneumococcal vaccine to 1983 warhorse
Apr 29, 2024 9:00am
GSK tips 12 blockbuster launches to soften HIV patent loss
Jan 31, 2024 7:45am
Merck strides onto Pfizer’s turf with pivotal vaccine data
Nov 28, 2023 8:20am
